Drug Drug Interaction Trial With Strong CYP3A4 Inhibitor (Itraconazole) in CYP2C19 Extensive Metabolizers and Poor Metabolizers
Clinical trial NCT02248259 · COMPLETED
Trial details
- NCT number
- NCT02248259
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-08
- Primary completion
- 2015-01-07
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.